A detailed history of Berger Financial Group, Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Berger Financial Group, Inc holds 5,065 shares of TMO stock, worth $2.65 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
5,065
Previous 5,102 0.73%
Holding current value
$2.65 Million
Previous $2.82 Million 11.02%
% of portfolio
0.27%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$531.86 - $624.21 $19,678 - $23,095
-37 Reduced 0.73%
5,065 $3.13 Million
Q2 2024

Aug 14, 2024

SELL
$541.52 - $599.02 $90,433 - $100,036
-167 Reduced 3.17%
5,102 $2.82 Million
Q1 2024

Apr 16, 2024

SELL
$528.82 - $599.43 $29,613 - $33,568
-56 Reduced 1.05%
5,269 $3.06 Million
Q4 2023

Feb 07, 2024

SELL
$431.41 - $532.94 $57,377 - $70,881
-133 Reduced 2.44%
5,325 $2.83 Million
Q3 2023

Nov 03, 2023

SELL
$498.29 - $574.41 $145,002 - $167,153
-291 Reduced 5.06%
5,458 $2.76 Million
Q2 2023

Aug 10, 2023

SELL
$508.46 - $591.13 $26,439 - $30,738
-52 Reduced 0.9%
5,749 $3 Million
Q1 2023

Apr 24, 2023

SELL
$535.0 - $604.82 $45,475 - $51,409
-85 Reduced 1.44%
5,801 $3.34 Million
Q4 2022

Jan 30, 2023

SELL
$484.71 - $571.37 $47,016 - $55,422
-97 Reduced 1.62%
5,886 $3.24 Million
Q3 2022

Oct 27, 2022

SELL
$507.19 - $604.49 $33,981 - $40,500
-67 Reduced 1.11%
5,983 $3.03 Million
Q2 2022

Aug 08, 2022

SELL
$500.9 - $612.21 $12,522 - $15,305
-25 Reduced 0.41%
6,050 $3.29 Million
Q1 2022

May 10, 2022

SELL
$524.0 - $644.92 $28,820 - $35,470
-55 Reduced 0.9%
6,075 $3.59 Million
Q4 2021

Jan 26, 2022

BUY
$569.0 - $667.24 $3.49 Million - $4.09 Million
6,130 New
6,130 $4.09 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Berger Financial Group, Inc Portfolio

Follow Berger Financial Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berger Financial Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berger Financial Group, Inc with notifications on news.